Dexmedetomidine Inhibits Inflammation and Angiogenesis and Alleviates Esophageal Cancer Progression through ITGA6 PI3K AKT Pathway: Dexmedetomidine Inhibits Esophageal Cancer Progression. Indian J Exp Biol 2026, 64 (01), 15-32. https://doi.org/10.56042/ijeb.v64i01.22881.